Barclay, N. L., Català, M. ., Jödicke, A. M., Prieto-Alhambra, D. ., Newby, D. ., Delmestri, A. ., … Moncusí, M. P. (2024). Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: a cohort study. Ther Adv Med Oncol, 16, 17588359241253115. http://doi.org/10.1177/17588359241253115
breast cancer
Hagberg, K. W., Vasilakis-Scaramozza, C. ., Persson, R. ., Neasham, D. ., Kafatos, G. ., & Jick, S. . (2023). Correctness and Completeness of Breast Cancer Diagnoses Recorded in UK CPRD Aurum and CPRD GOLD Databases: Comparison to Hospital Episode Statistics and Cancer Registry (Companion Paper 2). Clin Epidemiol, 15, 1193–1206. http://doi.org/10.2147/clep.s434829
Hagberg, K. W., Vasilakis-Scaramozza, C. ., Persson, R. ., Neasham, D. ., Kafatos, G. ., & Jick, S. . (2023). Presence of Breast Cancer Information Recorded in United Kingdom Primary Care Databases: Comparison of CPRD Aurum and CPRD GOLD (Companion Paper 1). Clin Epidemiol, 15, 1183–1192. http://doi.org/10.2147/clep.s434795
Khosrow-Khavar, F. ., Azoulay, L. ., Montastruc, J. L., Montastruc, F. ., & Renoux, C. . (2022). Aromatase inhibitors and the incidence of Parkinson disease: A population-based cohort study. Cancer. http://doi.org/10.1002/cncr.34208
Bromley, S. E., Matthews, A. ., Smeeth, L. ., Stanway, S. ., & Bhaskaran, K. . (2019). Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK. J Cancer Surviv. http://doi.org/10.1007/s11764-019-00782-w